Panama Will Be A Pharmaceutical Hub For The Cannabis Industry - And This Event Will Be Fundamental To Its Development

On September 1 and 2, 2022, LATAM CANN.BIZ will be held in Panama.

More than 40 experts, executives, medical professionals and political actors meet to discover the opportunities for economic development, investment and scientific advances in the medical and industrial cannabis industry.

Enter LATAM CANN.BIZ

On September 1 and 2, 2022, LATAM CANN.BIZ will be held in Panama City, at the Santa María Luxury Collection Hotel & Golf Resort. Executives, medical professionals, and political actors will meet to discover opportunities for investments, economic development, and scientific advances in the cannabis industry. The event will be held with the aim of bringing opportunities in the medical and industrial cannabis industry closer to the country.

The conference, considered the most important in Latin America in 2022, will bring together more than 40 executives, investors, political actors, patients, and medical professionals.

In October 2021, Panama adopted legal framework No. 242 that regulates the medicinal and therapeutic use of cannabis, its import, export, and cultivation, and creates a registry of patients, specialists, and companies.

It is estimated that the industry could generate an economic impact of close to 30 million dollars for Panama. 

“Panama has enormous competitive advantages and could quickly become an import and export hub for the entire world. The combination of elements such as its ports and logistics platform, its robust banking sector, and the confidence that its legal framework offers markets, creates a perfect environment for Panama, to strengthen its local market and the Latin American region," said Noemí Pérez, president of PRMedCann.Biz, a consulting firm focused on the cannabis industry.

LATAM CANN.BIZ is an event conceived as a bilingual interdisciplinary conference, in which global and regional trends will be addressed. Attendees will participate in discussions on the positive impact of the regulation of the medicinal and therapeutic use of cannabis on neighboring countries in terms of income, productivity, jobs, investment, and economic development. 

“The cannabis industry has developed successfully in several countries around the world, from the United States and Canada to Israel and Colombia. LATAM CANN.BIZ will bring accomplished experts and their knowledge to the public in Panama and Latin America in general”, said Javier Hasse, CEO of El Planteo and award-winning author specializing in cannabis.

Agribusiness can favor economic activity after the pandemic of COVID-19 and can foster long-term sustainable development. “Add to this [the fact] that the creation of this industry activates other economic segments such as security, transportation, technology, research, packaging, marketing, and insurance, it becomes a multiplier effect,” commented Ingrid Schmidt, President of LATAM CANN.BIZ.

It is estimated that for every dollar a patient invests in cannabis, an additional $2.5 is injected into the local economy.

This has been the experience of other jurisdictions similar to Panama. In Puerto Rico, for example, five years after the launch of the Industry, the number of direct jobs created exceeds 6,000 and retail sales are close to US$800 million, boosting the treasury with a sales tax contribution of more than US$85MM.

Top-Tier Speakers At LATAM CANN.BIZ

The event will feature local and international experts who will focus their presentations on issues of public policy, economic development, and health. In addition, this initiative is an opportunity to establish business contacts and networking for all the sectors involved.

Advances in medical research and biotechnology, that can promote the development of new pharmaceutical formulations, clinical documentation, and patents will be discussed. For those interested in this pharmaceutical segment, the Conference will feature local and international experts from North America, the Caribbean, Central America, South America, and Europe who will share their experiences and will bring global best practices for discussion.

The National Director of Pharmacy and Drugs from Panama, Elvia Lau, will be one of the speakers, as well as the lawyers Adolfo Linares, Carolina de la Guardia, Leroy Sheffer, and Carlos Hoyos; along with Carlos Ossas, activist and patient, Raymond D. Harari, an executive from Canalis Capital and Sandra Carrillo, medical specialist.

Renowned international speakers include Dr. Dedi Meiri, Mara Gordon, Julian Cohen CIO of Canopy Growth Corp. CGC, Pablo Zuanic, cannabis financial analyst from Cantor Fitzgerald, Juanjo Feijoo COO and CMO of Weedmaps MAPS, former Argentine legislator Facundo Garretón, Aras Azadian CEO of Avicanna AVCNF, Bob Hoban of Clark Hill, Scott Greiper, president of Viridian Capital Advisors, and José Bacellar of VerdeMed.

Photo: press conference announcing LatAm Cann.Biz